95 related articles for article (PubMed ID: 7766834)
1. Nerve growth factor treatment restores [3H]QNB binding site density in adult rat subjected to cortical infarction.
Liberini P; Reuben M; Clarke PB; Cuello AC
Neuroreport; 1995 Feb; 6(3):419-20. PubMed ID: 7766834
[TBL] [Abstract][Full Text] [Related]
2. Effects of propentofylline, a NGF synthesis stimulator, on alterations in muscarinic cholinergic receptors induced by basal forebrain lesion in rats.
Fuji K; Hiramatsu M; Hayashi S; Kameyama T; Nabeshima T
Neurosci Lett; 1993 Feb; 150(1):99-102. PubMed ID: 8469410
[TBL] [Abstract][Full Text] [Related]
3. Regulation of hippocampal muscarinic receptor function by chronic nerve growth factor treatment in adult rats with fimbrial transections.
Lapchak PA; Araujo DM; Hefti F
Neuroscience; 1993 Mar; 53(2):379-94. PubMed ID: 8388084
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173
[TBL] [Abstract][Full Text] [Related]
5. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
6. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
Norman AB; Creese I
Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
[TBL] [Abstract][Full Text] [Related]
7. Selective, unilateral cortical infarction increases striatal muscarinic receptor binding: potential evidence for cortical modulation of intrastriatal cholinergic transmission.
Filloux F; Liu TH; Hsu CY; Hunt MA; Wamsley JK
J Chem Neuroanat; 1990; 3(2):125-32. PubMed ID: 2340116
[TBL] [Abstract][Full Text] [Related]
8. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
[TBL] [Abstract][Full Text] [Related]
9. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
Norman AB; Eubanks JH; Creese I
J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
[TBL] [Abstract][Full Text] [Related]
10. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart.
Evans RA; Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1985 Dec; 235(3):612-8. PubMed ID: 3841156
[TBL] [Abstract][Full Text] [Related]
11. Region-specific changes in CNS muscarinic acetylcholine receptors in a rat model of hyperammonemia.
Rukmini Devi RP; Murthy CR
Biochem Pharmacol; 1998 Jul; 56(2):237-41. PubMed ID: 9698078
[TBL] [Abstract][Full Text] [Related]
12. Muscarinic acetylcholine receptors in bulk-isolated astrocytes of the hippocampus in the rat.
Ułas J
Acta Neurobiol Exp (Wars); 1988; 48(1):41-8. PubMed ID: 3407450
[TBL] [Abstract][Full Text] [Related]
13. Effects of bilateral ibotenate-induced lesions of the nucleus basalis magnocellularis upon selective cholinergic biochemical markers in the rat anterior cerebral cortex.
Watson M; Vickroy TW; Fibiger HC; Roeske WR; Yamamura HI
Brain Res; 1985 Nov; 346(2):387-91. PubMed ID: 3840399
[TBL] [Abstract][Full Text] [Related]
14. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
15. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
Lee W; Wolfe BB
Mol Pharmacol; 1989 Nov; 36(5):749-57. PubMed ID: 2555673
[TBL] [Abstract][Full Text] [Related]
16. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
17. Intracerebroventricular administration of nerve growth factor affects muscarinic cholinergic receptors in the cerebral cortex of neonatal rats.
Eva C; Fusco M; Brusa R; Schiavo N; Ricci Gamalero S; Vantini G; Genazzani E
Neurochem Int; 1994 Jan; 24(1):57-65. PubMed ID: 8130736
[TBL] [Abstract][Full Text] [Related]
18. Nerve growth factor preserves a critical motor period in rat striatum.
Wolansky MJ; Paratcha GC; Ibarra GR; Azcurra JM
J Neurobiol; 1999 Jan; 38(1):129-36. PubMed ID: 10027568
[TBL] [Abstract][Full Text] [Related]
19. Unexpected decrease in in vivo binding of [
Inoue O; Sato T; Kobayashi K; Gee A; Shukuri M; Zhang MR
Nucl Med Biol; 2018 Dec; 67():15-20. PubMed ID: 30380462
[TBL] [Abstract][Full Text] [Related]
20. Effects of chemical sympathectomy with 6-hydroxydopamine on alpha- and beta-adrenoceptors and muscarinic cholinoceptors in rat kidney.
Yamada S; Yamamura HI; Roeske WR
Eur J Pharmacol; 1986 Mar; 121(3):345-53. PubMed ID: 3009209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
